These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Studies on inclusion bodies in early and late demyelinating disease. Adams JM; Brown WJ Int Arch Allergy Appl Immunol; 1969; 36():Suppl:83-101. PubMed ID: 4906735 [No Abstract] [Full Text] [Related]
24. [Virus and demyelination: why suspect that a virus may be involved in the aetiology of multiple sclerosis?]. Fernández-Muñoz R; Celma-Serrat M Rev Neurol; 2002 Nov 16-30; 35(10):964-72. PubMed ID: 12436401 [TBL] [Abstract][Full Text] [Related]
25. Oligodendrocytes: the putative target cells of multiple sclerosis. Abramsky O Isr J Med Sci; 1982 Jan; 18(1):149-58. PubMed ID: 7040297 [No Abstract] [Full Text] [Related]
26. [Aspects of antiviral immunity in patients with multiple sclerosis]. Mayer M Cas Lek Cesk; 1985 Jul; 124(28):869-71. PubMed ID: 2411404 [No Abstract] [Full Text] [Related]
27. [Infections and natural killer cell]. Sendo F Nihon Rinsho; 1981 Jun; 39(6):2288-90. PubMed ID: 7311003 [No Abstract] [Full Text] [Related]
28. [Change in the activity of natural killer cells in normal subjects and in virus diseases on exposure to interferon in vitro]. Petrov RV; Saidov MZ; Koval'chuk LV; Sorokin AM; Kaganov BS Biull Eksp Biol Med; 1984 Apr; 97(4):438-40. PubMed ID: 6722306 [TBL] [Abstract][Full Text] [Related]
29. Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. McCoy L; Tsunoda I; Fujinami RS Autoimmunity; 2006 Feb; 39(1):9-19. PubMed ID: 16455578 [TBL] [Abstract][Full Text] [Related]
30. The search for an infectious agent: approaches explored for multiple sclerosis. Carp RI Birth Defects Orig Artic Ser; 1978; 14(5):89-109. PubMed ID: 687801 [No Abstract] [Full Text] [Related]
31. Natural killer cell activity in patients with multiple sclerosis given alpha interferon. Rice GP; Casali P; Merigan TC; Oldstone MB Ann Neurol; 1983 Sep; 14(3):333-8. PubMed ID: 6638954 [TBL] [Abstract][Full Text] [Related]
32. [Disseminated sclerosis and other demyelinating diseases of the nervous system]. Markov DA Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(11):1629-31. PubMed ID: 4872602 [No Abstract] [Full Text] [Related]
33. Multiple sclerosis immune complexes: an analysis of component antigens and antibodies. Coyle PK; Procyk-Dougherty Z Ann Neurol; 1984 Dec; 16(6):660-7. PubMed ID: 6098217 [TBL] [Abstract][Full Text] [Related]
34. [Polyspecific immune reaction in the central nervous system in autoimmune diseases with CNS involvement]. Graef IT; Henze T; Reiber H Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):587-91. PubMed ID: 7856266 [No Abstract] [Full Text] [Related]
35. Demyelinating diseases and certain virus infections. Adams JM Pathobiol Annu; 1972; 2():183-205. PubMed ID: 4359244 [No Abstract] [Full Text] [Related]
36. Cell-mediated immunity to isolated human oligodendroglia in multiple sclerosis. Myers LW; Ellison GW; Fewster ME; Wolfgram F Trans Am Neurol Assoc; 1975; 100():107-9. PubMed ID: 1226591 [No Abstract] [Full Text] [Related]
37. Search for viruses in multiple sclerosis. Koprowski H Neurology; 1976 Jun; 26(6 PT 2):80-2. PubMed ID: 179033 [No Abstract] [Full Text] [Related]